T R Browne, D C Poskanzer. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » AnimalsAnticholesteremic Agents/therapeutic useAnticoagulants/adverse effectsAnticoagulants/therapeutic useBlood Coagulation Disorders/chemically inducedCarotid Artery Diseases/surgeryCerebral Angiography/adverse effectsCerebrovascular Disorders/complicationsCerebrovascular Disorders/diagnostic imagingCerebrovascular Disorders/surgeryCerebrovascular Disorders/therapyDextrans/therapeutic useFibrinolytic Agents/therapeutic useHumansIntracranial Arteriosclerosis/diagnosisIntracranial Arteriosclerosis/drug therapyIntracranial Embolism and Thrombosis/drug therapyIntracranial Embolism and Thrombosis/surgeryIntracranial Embolism and Thrombosis/therapyIschemic Attack, Transient/diagnosisIschemic Attack, Transient/drug therapyIschemic Attack, Transient/surgeryPhysical Therapy ModalitiesPrognosisVasodilator Agents/therapeutic use
Substances： See more » Anticholesteremic AgentsAnticoagulantsDextransFibrinolytic AgentsVasodilator Agents
Year: 1969 PMID： 4897138 DOI： 10.1056/NEJM196909112811105
Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245